Loading…
Decreased core symptoms of mania and utilization of lithium/mood stabilizing anticonvulsants in U.S. bipolar I patients of African vs European ancestry
•Bipolar persons of African ancestry (AA), compared to persons of European ancestry (EA), presented with less core mania symptoms and more psychotic symptoms.•Compared to EA patients, AA patients reported less use of lithium and mood stabilizers and more use of atypical antipsychotics and select typ...
Saved in:
| Published in: | Journal of affective disorders 2020-01, Vol.260, p.361-365 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c353t-4db8d68f8f6be9d570e1c94d4a0dc6ba398db067fac62bf92c49096fc0afb4c73 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c353t-4db8d68f8f6be9d570e1c94d4a0dc6ba398db067fac62bf92c49096fc0afb4c73 |
| container_end_page | 365 |
| container_issue | |
| container_start_page | 361 |
| container_title | Journal of affective disorders |
| container_volume | 260 |
| creator | Akinhanmi, Margaret El-Amin, Suliman Balls-Berry, Joyce E. Vallender, Eric J. Ladner, Mark Geske, Jennifer Coombes, Brandon Biernacka, Joanna Kelsoe, John Frye, Mark A. |
| description | •Bipolar persons of African ancestry (AA), compared to persons of European ancestry (EA), presented with less core mania symptoms and more psychotic symptoms.•Compared to EA patients, AA patients reported less use of lithium and mood stabilizers and more use of atypical antipsychotics and select typical antipsychotics.•Differential symptom presentation may contribute to the diagnostic disparity in the AA patient group, and increased minority recruitment is necessary to comprehensively understand the contributions to misdiagnosis.
Misdiagnosis is common in bipolar disorder and disproportionally affects racial and ethnic minorities. There is interest in better understanding the contribution of differential symptomatic illness presentation to misdiagnosis.
Utilizing the Genetic Association Information Network (GAIN) public database, this study compared clinical phenomenology between bipolar patients of African vs European ancestry (AA = 415 vs EA = 480). The Diagnostic Interview for Genetic Studies (DIGS) was utilized to evaluate symptom endorsement contributing to diagnostic confirmation of bipolar I disorder (BPI) and lifetime medication use.
Elevated/euphoric mood was less endorsed in AA vs EA participants (p = 0.03). During the most severe episode of mania, AA participants, in comparison to EA participants, had a lower sum of manic symptoms (p = 0.006) and a higher rate of hallucinations (p = 0.01). During lifetime psychosis, AA participants, in comparison to EA participants, had a higher lifetime sum of delusions (p = 0.01) and hallucinations (p |
| doi_str_mv | 10.1016/j.jad.2019.09.022 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2295485894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016503271931211X</els_id><sourcerecordid>2295485894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-4db8d68f8f6be9d570e1c94d4a0dc6ba398db067fac62bf92c49096fc0afb4c73</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0EopfCA7BBXrJJajuJE4tV1T8qVWJRurb8MwZfJXawkytdXoTXraNbWCKNNCOdb47lOQh9pKSmhPKLfb1XtmaEipqUYuwV2tGubyrW0f412hWmq0jD-jP0Luc9IYSLnrxFZw3tGsF7ukN_rsEkUBksNjEBzsdpXuKUcXR4UsErrILF6-JH_1stPoZNGP3y06_TxRSjxXlRelN9-FHYxZsYDuuYy5ixD_ipfqyx9nMcVcL3eC4msEnF5tIlb1TAh4xv1hRnKLMKBvKSju_RG6fGDB9e-jl6ur35fvW1evh2d391-VCZpmuWqrV6sHxwg-MahO16AtSI1raKWMO1asRgNeG9U4Yz7QQzrSCCO0OU063pm3P0-eQ7p_hrLU_LyWcD46gCxDVLxkTXDt0g2oLSE2pSzDmBk3Pyk0pHSYnc8pB7WfKQWx6SlGKs7Hx6sV_1BPbfxt8ACvDlBED55MFDktmUAxmwPoFZpI3-P_bPXCmfHQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2295485894</pqid></control><display><type>article</type><title>Decreased core symptoms of mania and utilization of lithium/mood stabilizing anticonvulsants in U.S. bipolar I patients of African vs European ancestry</title><source>ScienceDirect Journals</source><creator>Akinhanmi, Margaret ; El-Amin, Suliman ; Balls-Berry, Joyce E. ; Vallender, Eric J. ; Ladner, Mark ; Geske, Jennifer ; Coombes, Brandon ; Biernacka, Joanna ; Kelsoe, John ; Frye, Mark A.</creator><creatorcontrib>Akinhanmi, Margaret ; El-Amin, Suliman ; Balls-Berry, Joyce E. ; Vallender, Eric J. ; Ladner, Mark ; Geske, Jennifer ; Coombes, Brandon ; Biernacka, Joanna ; Kelsoe, John ; Frye, Mark A. ; Bipolar Genome Study (BiGS)</creatorcontrib><description>•Bipolar persons of African ancestry (AA), compared to persons of European ancestry (EA), presented with less core mania symptoms and more psychotic symptoms.•Compared to EA patients, AA patients reported less use of lithium and mood stabilizers and more use of atypical antipsychotics and select typical antipsychotics.•Differential symptom presentation may contribute to the diagnostic disparity in the AA patient group, and increased minority recruitment is necessary to comprehensively understand the contributions to misdiagnosis.
Misdiagnosis is common in bipolar disorder and disproportionally affects racial and ethnic minorities. There is interest in better understanding the contribution of differential symptomatic illness presentation to misdiagnosis.
Utilizing the Genetic Association Information Network (GAIN) public database, this study compared clinical phenomenology between bipolar patients of African vs European ancestry (AA = 415 vs EA = 480). The Diagnostic Interview for Genetic Studies (DIGS) was utilized to evaluate symptom endorsement contributing to diagnostic confirmation of bipolar I disorder (BPI) and lifetime medication use.
Elevated/euphoric mood was less endorsed in AA vs EA participants (p = 0.03). During the most severe episode of mania, AA participants, in comparison to EA participants, had a lower sum of manic symptoms (p = 0.006) and a higher rate of hallucinations (p = 0.01). During lifetime psychosis, AA participants, in comparison to EA participants, had a higher lifetime sum of delusions (p = 0.01) and hallucinations (p < 0.0001). AA participants reported lower use of lithium (p < 0.0001) and mood stabilizing anticonvulsants (p = 0.0003).
The differential rate of manic and psychotic symptom endorsement from a semi-structured diagnostic interview may represent differential illness presentation based on biological differences or racial or study biases (e.g. ascertainment). Increased minority recruitment in bipolar research is therefore a necessary future direction.
Recall and interviewer bias may affect study results, but are likely diminished by the alignment of symptom endorsement and medication use.</description><identifier>ISSN: 0165-0327</identifier><identifier>ISSN: 1573-2517</identifier><identifier>EISSN: 1573-2517</identifier><identifier>DOI: 10.1016/j.jad.2019.09.022</identifier><identifier>PMID: 31539671</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Anticonvulsants - therapeutic use ; Antimanic Agents - therapeutic use ; Bipolar ; Bipolar Disorder - drug therapy ; Bipolar Disorder - ethnology ; Bipolar Disorder - psychology ; Black or African American ; Black People - psychology ; Databases, Factual ; Female ; Health disparity ; Humans ; Lithium ; Lithium Compounds - therapeutic use ; Male ; Middle Aged ; Patient Acceptance of Health Care - ethnology ; Pilot Projects ; Psychosis ; United States ; White People - psychology</subject><ispartof>Journal of affective disorders, 2020-01, Vol.260, p.361-365</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-4db8d68f8f6be9d570e1c94d4a0dc6ba398db067fac62bf92c49096fc0afb4c73</citedby><cites>FETCH-LOGICAL-c353t-4db8d68f8f6be9d570e1c94d4a0dc6ba398db067fac62bf92c49096fc0afb4c73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31539671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akinhanmi, Margaret</creatorcontrib><creatorcontrib>El-Amin, Suliman</creatorcontrib><creatorcontrib>Balls-Berry, Joyce E.</creatorcontrib><creatorcontrib>Vallender, Eric J.</creatorcontrib><creatorcontrib>Ladner, Mark</creatorcontrib><creatorcontrib>Geske, Jennifer</creatorcontrib><creatorcontrib>Coombes, Brandon</creatorcontrib><creatorcontrib>Biernacka, Joanna</creatorcontrib><creatorcontrib>Kelsoe, John</creatorcontrib><creatorcontrib>Frye, Mark A.</creatorcontrib><creatorcontrib>Bipolar Genome Study (BiGS)</creatorcontrib><title>Decreased core symptoms of mania and utilization of lithium/mood stabilizing anticonvulsants in U.S. bipolar I patients of African vs European ancestry</title><title>Journal of affective disorders</title><addtitle>J Affect Disord</addtitle><description>•Bipolar persons of African ancestry (AA), compared to persons of European ancestry (EA), presented with less core mania symptoms and more psychotic symptoms.•Compared to EA patients, AA patients reported less use of lithium and mood stabilizers and more use of atypical antipsychotics and select typical antipsychotics.•Differential symptom presentation may contribute to the diagnostic disparity in the AA patient group, and increased minority recruitment is necessary to comprehensively understand the contributions to misdiagnosis.
Misdiagnosis is common in bipolar disorder and disproportionally affects racial and ethnic minorities. There is interest in better understanding the contribution of differential symptomatic illness presentation to misdiagnosis.
Utilizing the Genetic Association Information Network (GAIN) public database, this study compared clinical phenomenology between bipolar patients of African vs European ancestry (AA = 415 vs EA = 480). The Diagnostic Interview for Genetic Studies (DIGS) was utilized to evaluate symptom endorsement contributing to diagnostic confirmation of bipolar I disorder (BPI) and lifetime medication use.
Elevated/euphoric mood was less endorsed in AA vs EA participants (p = 0.03). During the most severe episode of mania, AA participants, in comparison to EA participants, had a lower sum of manic symptoms (p = 0.006) and a higher rate of hallucinations (p = 0.01). During lifetime psychosis, AA participants, in comparison to EA participants, had a higher lifetime sum of delusions (p = 0.01) and hallucinations (p < 0.0001). AA participants reported lower use of lithium (p < 0.0001) and mood stabilizing anticonvulsants (p = 0.0003).
The differential rate of manic and psychotic symptom endorsement from a semi-structured diagnostic interview may represent differential illness presentation based on biological differences or racial or study biases (e.g. ascertainment). Increased minority recruitment in bipolar research is therefore a necessary future direction.
Recall and interviewer bias may affect study results, but are likely diminished by the alignment of symptom endorsement and medication use.</description><subject>Adult</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Antimanic Agents - therapeutic use</subject><subject>Bipolar</subject><subject>Bipolar Disorder - drug therapy</subject><subject>Bipolar Disorder - ethnology</subject><subject>Bipolar Disorder - psychology</subject><subject>Black or African American</subject><subject>Black People - psychology</subject><subject>Databases, Factual</subject><subject>Female</subject><subject>Health disparity</subject><subject>Humans</subject><subject>Lithium</subject><subject>Lithium Compounds - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Acceptance of Health Care - ethnology</subject><subject>Pilot Projects</subject><subject>Psychosis</subject><subject>United States</subject><subject>White People - psychology</subject><issn>0165-0327</issn><issn>1573-2517</issn><issn>1573-2517</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1TAQhS0EopfCA7BBXrJJajuJE4tV1T8qVWJRurb8MwZfJXawkytdXoTXraNbWCKNNCOdb47lOQh9pKSmhPKLfb1XtmaEipqUYuwV2tGubyrW0f412hWmq0jD-jP0Luc9IYSLnrxFZw3tGsF7ukN_rsEkUBksNjEBzsdpXuKUcXR4UsErrILF6-JH_1stPoZNGP3y06_TxRSjxXlRelN9-FHYxZsYDuuYy5ixD_ipfqyx9nMcVcL3eC4msEnF5tIlb1TAh4xv1hRnKLMKBvKSju_RG6fGDB9e-jl6ur35fvW1evh2d391-VCZpmuWqrV6sHxwg-MahO16AtSI1raKWMO1asRgNeG9U4Yz7QQzrSCCO0OU063pm3P0-eQ7p_hrLU_LyWcD46gCxDVLxkTXDt0g2oLSE2pSzDmBk3Pyk0pHSYnc8pB7WfKQWx6SlGKs7Hx6sV_1BPbfxt8ACvDlBED55MFDktmUAxmwPoFZpI3-P_bPXCmfHQ</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Akinhanmi, Margaret</creator><creator>El-Amin, Suliman</creator><creator>Balls-Berry, Joyce E.</creator><creator>Vallender, Eric J.</creator><creator>Ladner, Mark</creator><creator>Geske, Jennifer</creator><creator>Coombes, Brandon</creator><creator>Biernacka, Joanna</creator><creator>Kelsoe, John</creator><creator>Frye, Mark A.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200101</creationdate><title>Decreased core symptoms of mania and utilization of lithium/mood stabilizing anticonvulsants in U.S. bipolar I patients of African vs European ancestry</title><author>Akinhanmi, Margaret ; El-Amin, Suliman ; Balls-Berry, Joyce E. ; Vallender, Eric J. ; Ladner, Mark ; Geske, Jennifer ; Coombes, Brandon ; Biernacka, Joanna ; Kelsoe, John ; Frye, Mark A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-4db8d68f8f6be9d570e1c94d4a0dc6ba398db067fac62bf92c49096fc0afb4c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Antimanic Agents - therapeutic use</topic><topic>Bipolar</topic><topic>Bipolar Disorder - drug therapy</topic><topic>Bipolar Disorder - ethnology</topic><topic>Bipolar Disorder - psychology</topic><topic>Black or African American</topic><topic>Black People - psychology</topic><topic>Databases, Factual</topic><topic>Female</topic><topic>Health disparity</topic><topic>Humans</topic><topic>Lithium</topic><topic>Lithium Compounds - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Acceptance of Health Care - ethnology</topic><topic>Pilot Projects</topic><topic>Psychosis</topic><topic>United States</topic><topic>White People - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akinhanmi, Margaret</creatorcontrib><creatorcontrib>El-Amin, Suliman</creatorcontrib><creatorcontrib>Balls-Berry, Joyce E.</creatorcontrib><creatorcontrib>Vallender, Eric J.</creatorcontrib><creatorcontrib>Ladner, Mark</creatorcontrib><creatorcontrib>Geske, Jennifer</creatorcontrib><creatorcontrib>Coombes, Brandon</creatorcontrib><creatorcontrib>Biernacka, Joanna</creatorcontrib><creatorcontrib>Kelsoe, John</creatorcontrib><creatorcontrib>Frye, Mark A.</creatorcontrib><creatorcontrib>Bipolar Genome Study (BiGS)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of affective disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akinhanmi, Margaret</au><au>El-Amin, Suliman</au><au>Balls-Berry, Joyce E.</au><au>Vallender, Eric J.</au><au>Ladner, Mark</au><au>Geske, Jennifer</au><au>Coombes, Brandon</au><au>Biernacka, Joanna</au><au>Kelsoe, John</au><au>Frye, Mark A.</au><aucorp>Bipolar Genome Study (BiGS)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased core symptoms of mania and utilization of lithium/mood stabilizing anticonvulsants in U.S. bipolar I patients of African vs European ancestry</atitle><jtitle>Journal of affective disorders</jtitle><addtitle>J Affect Disord</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>260</volume><spage>361</spage><epage>365</epage><pages>361-365</pages><issn>0165-0327</issn><issn>1573-2517</issn><eissn>1573-2517</eissn><abstract>•Bipolar persons of African ancestry (AA), compared to persons of European ancestry (EA), presented with less core mania symptoms and more psychotic symptoms.•Compared to EA patients, AA patients reported less use of lithium and mood stabilizers and more use of atypical antipsychotics and select typical antipsychotics.•Differential symptom presentation may contribute to the diagnostic disparity in the AA patient group, and increased minority recruitment is necessary to comprehensively understand the contributions to misdiagnosis.
Misdiagnosis is common in bipolar disorder and disproportionally affects racial and ethnic minorities. There is interest in better understanding the contribution of differential symptomatic illness presentation to misdiagnosis.
Utilizing the Genetic Association Information Network (GAIN) public database, this study compared clinical phenomenology between bipolar patients of African vs European ancestry (AA = 415 vs EA = 480). The Diagnostic Interview for Genetic Studies (DIGS) was utilized to evaluate symptom endorsement contributing to diagnostic confirmation of bipolar I disorder (BPI) and lifetime medication use.
Elevated/euphoric mood was less endorsed in AA vs EA participants (p = 0.03). During the most severe episode of mania, AA participants, in comparison to EA participants, had a lower sum of manic symptoms (p = 0.006) and a higher rate of hallucinations (p = 0.01). During lifetime psychosis, AA participants, in comparison to EA participants, had a higher lifetime sum of delusions (p = 0.01) and hallucinations (p < 0.0001). AA participants reported lower use of lithium (p < 0.0001) and mood stabilizing anticonvulsants (p = 0.0003).
The differential rate of manic and psychotic symptom endorsement from a semi-structured diagnostic interview may represent differential illness presentation based on biological differences or racial or study biases (e.g. ascertainment). Increased minority recruitment in bipolar research is therefore a necessary future direction.
Recall and interviewer bias may affect study results, but are likely diminished by the alignment of symptom endorsement and medication use.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31539671</pmid><doi>10.1016/j.jad.2019.09.022</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0165-0327 |
| ispartof | Journal of affective disorders, 2020-01, Vol.260, p.361-365 |
| issn | 0165-0327 1573-2517 1573-2517 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2295485894 |
| source | ScienceDirect Journals |
| subjects | Adult Anticonvulsants - therapeutic use Antimanic Agents - therapeutic use Bipolar Bipolar Disorder - drug therapy Bipolar Disorder - ethnology Bipolar Disorder - psychology Black or African American Black People - psychology Databases, Factual Female Health disparity Humans Lithium Lithium Compounds - therapeutic use Male Middle Aged Patient Acceptance of Health Care - ethnology Pilot Projects Psychosis United States White People - psychology |
| title | Decreased core symptoms of mania and utilization of lithium/mood stabilizing anticonvulsants in U.S. bipolar I patients of African vs European ancestry |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T13%3A49%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20core%20symptoms%20of%20mania%20and%20utilization%20of%20lithium/mood%20stabilizing%20anticonvulsants%20in%20U.S.%20bipolar%20I%20patients%20of%20African%20vs%20European%20ancestry&rft.jtitle=Journal%20of%20affective%20disorders&rft.au=Akinhanmi,%20Margaret&rft.aucorp=Bipolar%20Genome%20Study%20(BiGS)&rft.date=2020-01-01&rft.volume=260&rft.spage=361&rft.epage=365&rft.pages=361-365&rft.issn=0165-0327&rft.eissn=1573-2517&rft_id=info:doi/10.1016/j.jad.2019.09.022&rft_dat=%3Cproquest_cross%3E2295485894%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-4db8d68f8f6be9d570e1c94d4a0dc6ba398db067fac62bf92c49096fc0afb4c73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2295485894&rft_id=info:pmid/31539671&rfr_iscdi=true |